Lytix Biopharma AS 6BG.SG
€0.75 €0.01 (0.81%) 1D
Last Updated: Sep 11, 12:00 AM·XSTU
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Lytix Biopharma AS Stock Halal?
Shariah Compliance Analysis of 6BG.SG Stock
Germany Health Care Micro Cap No. As of September 2026, Lytix Biopharma AS (6BG.SG) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Lytix Biopharma AS does not pass Musaffa's business and financial screening criteria.
Lytix Biopharma AS engages in the development of novel drugs for the treatment of resistant bacterial and fungal infections, as well as oncology treatments. The firm is involved in development, marketing and sales of pharmaceutical and biotechnology products, as well as related activities. Lytix Biopharma AS developing cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. Lytix Biopharma molecules kill cancer cells, including resistant cells, and expose their internal components to the immune system. This results in uptake of tumor antigens and activation of tumor antigen-presenting cells, thereby generating a broad and long-lasting systemic T-cell response that overcomes tumor heterogeneity. Lytix Biopharma molecules can work in a wide variety of cancer indications and settings, both as mono- and combination therapies.
6BG.SG Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Lytix Biopharma AS is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Lytix Biopharma AS (6BG.SG) Chart
Financial Metrics & Statements of Lytix Biopharma AS (6BG.SG)
FAQ's for Lytix Biopharma AS (6BG.SG)
- As of September 2026, Lytix Biopharma AS 6BG.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lytix Biopharma AS using these criteria to determine its compliance status.
- Muslim investors may consider investing in Lytix Biopharma AS if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Lytix Biopharma AS by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Lytix Biopharma AS may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Lytix Biopharma AS on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Lytix Biopharma AS (6BG.SG)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
